Researchers at Thomas Jefferson University have found the method they developed to image the prostate appears to be much better at detecting prostate cancer than any other test — radiographical, biopsy or blood — in use today. Read the article.
New imaging test detects prostate cancer much better than any other tests in use today Read More »
A new genomic test, Oncotype DX, gauges how lethal a tumor is by looking at the expression of 17 genes in the tumor. Read the article.
New Diagnostic Tools for Prostate Cancer Read More »
A recent study out of Johns Hopkins shows that a new and simple grading system may be effective for predicting outcomes in men with prostate cancer. In fact, the researchers say the test — in an analysis of 20,000 men — appears to be an improvement over the Gleason grading system, the current standard. Read the article.
New Prostate Cancer Grading System Found Superior to Gleason System Read More »
MRF-TB (magnetic resonance imaging-ultrasound fusion targeted prostate biopsy) may improve the detection of prostate cancer in men presenting for prostate biopsy. In men presenting for primary prostate biopsy MRF-TB detects more high grade cancers than systematic biopsy. Most cancers detected by systematic biopsy and not by MRF-TB are at clinically low risk. Prebiopsy magnetic resonance imaging followed by MRF-TB decreases the detection of low risk cancers while significantly improving the detection and risk stratification of high grade disease. Read the article.
MRI-Ultrasound Fusion Biopsy Detects High-Grade Prostate Cancer Read More »
Dr. Eleftherios Diamandis, a researcher at Toronto’s Mount Sinai Hospital, would like a better alternative that could reduce unnecessary biopsies. Dr. Diamandis plans to spend the next two years developing a non-invasive test that can help determine when high PSA levels warrant concern. To do this, he will zero in on genetic mutations found in the semen of men with prostate cancer and use those biomarkers to screen other men for the disease. Read the article.
Semen-based test for diagnosing prostate cancer could reduce unnecessary biopsies Read More »
A study from Karolinska Institutet in Sweden shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA. The new test, which has undergone trial in 58,818 men, discovers aggressive cancer earlier and reduces the number of false positive tests and unnecessary biopsies. Read the article.
New test for prostate cancer significantly improves prostate cancer screening Read More »
A device used to protect American marines from anthrax during the Gulf War is now safeguarding some Canadian men against aggressive prostate cancer thanks to the ingenuity of a London scientist. The device is so precise and quick, in just three or four minutes, using just a teardrop of blood, a doctor can see if a patient has a typical prostate cancer, which grows slowly, or an ominous type that must be treated aggressively. Read the article.
Former military tool to target prostate cancer Read More »
Researchers in England have developed a new diagnostic test that can detect urology-related cancers by ‘smelling’ the diseases in urine samples. The new procedure, inspired by dogs’ ability to sniff out melanomas, could eliminate the need for painful probes and the prostate-specific antigen (PSA) blood test, both of which are invasive and seen as a factor behind men not visiting the doctor with prostate problems. Read the article.
New prostate cancer test can ‘smell’ the disease in men’s urine Read More »
September 2015 Scotiabank Awareness Night Prostate Cancer – we need to know more Dr. John Bartlett Ontario Institute of Cancer Research BSc, PhD, FRCPath Program Director, Transformative Pathology, Ontario Institute for Cancer Research (OICR). Director, Ontario Tumour Bank Honorary Professor, College of Medicine and Veterinary Medicine, University of Edinburg This video it not of the actual presentation, but was produced later and contains the essentials of that presentation. It is considerable shorter than the actual presentation. CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 11:08 hours
Video: Dr. John Bartlett – “Prostate Cancer – we need to know more” Read More »
A new standard for evaluating MR images to diagnose prostate cancer has been agreed upon by international radiological institutions and is now published in the journal European Urology. The new procedure reduces the over-diagnosis of insignificant cancers by up to 89 percent and assists in the diagnosis of up to 13 percent more life-threatening tumors than current procedures. Read the article.
International institutions agree on standard for using MR to diagnose prostate cancer Read More »